Ahmed Sewify, Maxence Lavaill, Dermot O'Rourke, Maria Antico, Peter Pivonka, Davide Fontanarosa, Saulo Martelli
{"title":"Non-contact tracking of shoulder bones using ultrasound and stereophotogrammetry.","authors":"Ahmed Sewify, Maxence Lavaill, Dermot O'Rourke, Maria Antico, Peter Pivonka, Davide Fontanarosa, Saulo Martelli","doi":"10.3389/fbioe.2025.1514568","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We explored the integration of 3D ultrasound (US) imaging with motion capture technology for non-invasively tracking bones of the shoulder district during normal activity. Our study aimed to demonstrate <i>ex-vivo</i> the proposed 3D US method's feasibility and accuracy of tracking shoulder bones in a controlled cadaveric shoulder positioned in various arm elevations (low, mid and high).</p><p><strong>Method: </strong>We registered previously acquired full bone shapes to spatially small bony surface patches segmented from 3D US. The bone registration approach used was based on <i>in silico</i> analyses that investigated the effects of different - 1) registration algorithms (Iterative-Closest-Point-ICP, and Coherent Point Drift-CPD) and 2) initial estimate levels of the bone model pose relative to the targeted final bone pose-on the overall registration efficiency and accuracy in a controlled environment.</p><p><strong>Results: </strong>CPD provided the highest accuracy in the simulation at the cost of 8x longer computation compared to ICP. The RMSE errors were <1 mm for the humerus and scapula at all elevations. <i>Ex-vivo</i>, the CPD registration errors were (Humerus = 2 mm and Scapula = 13.9 mm) (Humerus = 7.2 mm and Scapula = 16.8 mm) and (Humerus = 14.28 mm and Scapula = 27.5 mm), for low, medium and high elevations respectively.</p><p><strong>Conclusion: </strong>In summary, we demonstrated the feasibility and accuracy of tracking shoulder bones with 3D US in a simulation and a cadaveric experiment. We discovered that CPD may be a more suitable registration method for the task than ICP. We also discussed that 3D US with motion capture technology is very promising for dynamic bone tracking, but the US technology may not be ready for the task yet.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1514568"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11839626/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1514568","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: We explored the integration of 3D ultrasound (US) imaging with motion capture technology for non-invasively tracking bones of the shoulder district during normal activity. Our study aimed to demonstrate ex-vivo the proposed 3D US method's feasibility and accuracy of tracking shoulder bones in a controlled cadaveric shoulder positioned in various arm elevations (low, mid and high).
Method: We registered previously acquired full bone shapes to spatially small bony surface patches segmented from 3D US. The bone registration approach used was based on in silico analyses that investigated the effects of different - 1) registration algorithms (Iterative-Closest-Point-ICP, and Coherent Point Drift-CPD) and 2) initial estimate levels of the bone model pose relative to the targeted final bone pose-on the overall registration efficiency and accuracy in a controlled environment.
Results: CPD provided the highest accuracy in the simulation at the cost of 8x longer computation compared to ICP. The RMSE errors were <1 mm for the humerus and scapula at all elevations. Ex-vivo, the CPD registration errors were (Humerus = 2 mm and Scapula = 13.9 mm) (Humerus = 7.2 mm and Scapula = 16.8 mm) and (Humerus = 14.28 mm and Scapula = 27.5 mm), for low, medium and high elevations respectively.
Conclusion: In summary, we demonstrated the feasibility and accuracy of tracking shoulder bones with 3D US in a simulation and a cadaveric experiment. We discovered that CPD may be a more suitable registration method for the task than ICP. We also discussed that 3D US with motion capture technology is very promising for dynamic bone tracking, but the US technology may not be ready for the task yet.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.